Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers

Proteomics - Clinical Applications

Volumn 7, Issue 9-10, 2013, Pages 607-617

  Ueda, Koji ^a  

^a RIKEN   (Japan)

Author keywords

Biomarker; Cancer; Glycoproteomics; Mass spectrometry; Serum

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE; GLYCOPEPTIDE; LECTIN; OLIGOSACCHARIDE; TUMOR MARKER;

BINDING AFFINITY; BINDING SITE; CARBOHYDRATE ANALYSIS; COLUMN CHROMATOGRAPHY; ENERGY RESOLVED OXONIUM ION MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; INDUSTRIALIZATION; ION MONITORING; LIQUID CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; ANIMAL; CARBOHYDRATE METABOLISM; GLYCOBIOLOGY; INDUSTRY; METABOLISM; NEOPLASM; PROCEDURES;

ANIMALS; BIOMARKERS, TUMOR; CARBOHYDRATE METABOLISM; GLYCOMICS; HUMANS; INDUSTRY; NEOPLASMS; PROTEOMICS;

EID: 84885908937     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200123     Document Type: Review

References (104)

1. Anderson, N. L., The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem. 2010, 56, 177-185.
2. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
3. Ueda, K., Saichi, N., Takami, S., Kang, D. et al., A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. PLoS One 2011, 6, e18567.
4. Schulz-Knappe, P., Zucht, H. D., Heine, G., Jurgens, M. et al., Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb. Chem. High Throughput Screen. 2001, 4, 207-217.
5. Machtejevas, E., Andrecht, S., Lubda, D., Unger, K. K., Monolithic silica columns of various format in automated sample clean-up/multidimensional liquid chromatography/mass spectrometry for peptidomics. J. Chromatogr. A 2007, 1144, 97-101.
6. Fogli, A., Bulet, P., Peptidomics analysis of lymphoblastoid cell lines. Methods Mol. Biol. 2010, 615, 247-257.
7. Overall, C. M., Dean, R. A., Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 2006, 25, 69-75.
8. Doucet, A., Butler, G. S., Rodriguez, D., Prudova, A. et al., Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Mol. Cell. Proteomics 2008, 7, 1925-1951.
9. Butler, G. S., Dean, R. A., Smith, D., Overall, C. M., Membrane protease degradomics: proteomic identification and quantification of cell surface protease substrates. Methods Mol. Biol. 2009, 528, 159-176.
10. Huesgen, P. F., Overall, C. M., N- and C-terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification. Physiol. Plant. 2012, 145, 5-17.
11. Wejda, M., Impens, F., Takahashi, N., Van Damme, P. et al., Degradomics reveals that cleavage specificity profiles of caspase-2 and effector caspases are alike. J. Biol. Chem. 2012, 287, 33983-33995.
12. Wehr, A. Y., Hwang, W. T., Blair, I. A., Yu, K. H., Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry. J. Proteome Res. 2012, 11, 1749-1758.
13. Shi, T., Zhou, J. Y., Gritsenko, M. A., Hossain, M. et al., IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery. Methods 2012, 56, 246-253.
14. Koutroukides, T. A., Guest, P. C., Leweke, F. M., Bailey, D. M. et al., Characterization of the human serum depletome by label-free shotgun proteomics. J. Sep. Sci. 2011, 34, 1621-1626.
15. Beer, L. A., Tang, H. Y., Sriswasdi, S., Barnhart, K. T. et al., Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J. Proteome Res. 2011, 10, 1126-1138.
16. Berven, F. S., Ahmad, R., Clauser, K. R., Carr, S. A., Optimizing performance of glycopeptide capture for plasma proteomics. J. Proteome Res. 2010, 9, 1706-1715.
17. Jagtap, P., Bandhakavi, S., Higgins, L., McGowan, T. et al., Workflow for analysis of high mass accuracy salivary data set using MaxQuant and ProteinPilot search algorithm. Proteomics 2012, 12, 1726-1730.
18. Milan, E., Lazzari, C., Anand, S., Floriani, I. et al., SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors. J. Proteomics 2012, 76, 91-101.
19. Righetti, P. G., Boschetti, E., The ProteoMiner and the FortyNiners: searching for gold nuggets in the proteomic arena. Mass Spectrom. Rev. 2008, 27, 596-608.
20. Boschetti, E., Righetti, P. G., The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J. Proteomics 2008, 71, 255-264.
21. Hartwig, S., Czibere, A., Kotzka, J., Passlack, W. et al., Combinatorial hexapeptide ligand libraries (ProteoMiner): an innovative fractionation tool for differential quantitative clinical proteomics. Arch. Physiol. Biochem. 2009, 115, 155-160.
22. Fonslow, B. R., Carvalho, P. C., Academia, K., Freeby, S. et al., Improvements in proteomic metrics of low abundance proteins through proteome equalization using ProteoMiner prior to MudPIT. J. Proteome Res. 2011, 10, 3690-3700.
23. Hekmat, O., He, S., Warren, R. A., Withers, S. G., A mechanism-based ICAT strategy for comparing relative expression and activity levels of glycosidases in biological systems. J. Proteome Res. 2008, 7, 3282-3292.
24. Kang, X., Sun, L., Guo, K., Shu, H. et al., Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS. J. Cancer Res. Clin. Oncol. 2010, 136, 1151-1159.
25. Ramus, C., Gonzalez de Peredo, A., Dahout, C., Gallagher, M. et al., An optimized strategy for ICAT quantification of membrane proteins. Mol. Cell. Proteomics 2006, 5, 68-78.
26. Sethuraman, M., McComb, M. E., Huang, H., Huang, S. et al., Isotope-coded affinity tag (ICAT) approach to redox proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in complex protein mixtures. J. Proteome Res. 2004, 3, 1228-1233.
27. Yan, W., Lee, H., Deutsch, E. W., Lazaro, C. A. et al., A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry. Mol. Cell. Proteomics 2004, 3, 1039-1041.
28. Li, J., Steen, H., Gygi, S. P., Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents: the yeast salinity stress response. Mol. Cell. Proteomics 2003, 2, 1198-1204.
29. Ueda, K., Katagiri, T., Shimada, T., Irie, S. et al., Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J. Proteome Res. 2007, 6, 3475-3483.
30. Iida, T., Kuyama, H., Watanabe, M., Toda, C. et al., Rapid and efficient MALDI-TOF MS peak detection of 2-nitrobenzenesulfenyl-labeled peptides using the combination of HPLC and an automatic spotting apparatus. J. Biomol. Tech. 2006, 17, 333-341.
31. Ou, K., Kesuma, D., Ganesan, K., Yu, K. et al., Quantitative profiling of drug-associated proteomic alterations by combined 2-nitrobenzenesulfenyl chloride (NBS) isotope labeling and 2DE/MS identification. J. Proteome Res. 2006, 5, 2194-2206.
32. Matsuo, E., Toda, C., Watanabe, M., Ojima, N. et al., Selective detection of 2-nitrobenzenesulfenyl-labeled peptides by matrix-assisted laser desorption/ionization-time of flight mass spectrometry using a novel matrix. Proteomics 2006, 6, 2042-2049.
33. Matsuo, E., Toda, C., Watanabe, M., Iida, T. et al., Improved 2-nitrobenzenesulfenyl method: optimization of the protocol and improved enrichment for labeled peptides. Rapid Commun. Mass Spectrom. 2006, 20, 31-38.
34. Kuyama, H., Watanabe, M., Toda, C., Ando, E. et al., An approach to quantitative proteome analysis by labeling tryptophan residues. Rapid Commun. Mass Spectrom. 2003, 17, 1642-1650.
35. Kurogochi, M., Amano, M., Fumoto, M., Takimoto, A. et al., Reverse glycoblotting allows rapid-enrichment glycoproteomics of biopharmaceuticals and disease-related biomarkers. Angew. Chem.Int. Ed. Engl. 2007, 46, 8808-8813.
36. Kurogochi, M., Matsushista, T., Amano, M., Furukawa, J. et al., Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay. Mol. Cell. Proteomics 2010, 9, 2354-2368.
37. Ziegler, A., Cerciello, F., Bigosch, C., Bausch-Fluck, D. et al., Proteomic surfaceome analysis of mesothelioma. Lung Cancer 2012, 75, 189-196.
38. Gundry, R. L., Riordon, D. R., Tarasova, Y., Chuppa, S. et al., A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol. Cell. Proteomics 2012, 11, 303-316.
39. Danzer, C., Eckhardt, K., Schmidt, A., Fankhauser, N. et al., Comprehensive description of the N-glycoproteome of mouse pancreatic beta-cells and human islets. J. Proteome Res. 2012, 11, 1598-1608.
40. Bausch-Fluck, D., Hofmann, A., Wollscheid, B., Cell surface capturing technologies for the surfaceome discovery of hepatocytes. Methods Mol. Biol. 2012, 909, 1-16.
41. Kovarova, H., Gadher, S. J., Wollscheid, B., Focus on stem cell proteomics. Proteomics 2011, 11, 3943-3945.
42. Wollscheid, B., Bausch-Fluck, D., Henderson, C., O'Brien, R. et al., Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol. 2009, 27, 378-386.
43. Liu, L., Zhang, Y., Zhang, L., Yan, G. et al., Highly specific revelation of rat serum glycopeptidome by boronic acid-functionalized mesoporous silica. Anal. Chim. Acta 2012, 753, 64-72.
44. Xu, Y., Zhang, L., Lu, H., Yang, P., On-plate enrichment of glycopeptides by using boronic acid functionalized gold-coated Si wafer. Proteomics 2010, 10, 1079-1086.
45. Tang, J., Liu, Y., Qi, D., Yao, G. et al., On-plate-selective enrichment of glycopeptides using boronic acid-modified gold nanoparticles for direct MALDI-QIT-TOF MS analysis. Proteomics 2009, 9, 5046-5055.
46. Zhu, J., Wang, F., Chen, R., Cheng, K. et al., Centrifugation assisted microreactor enables facile integration of trypsin digestion, hydrophilic interaction chromatography enrichment, and on-column deglycosylation for rapid and sensitive N-glycoproteome analysis. Anal. Chem. 2012, 84, 5146-5153.
47. Xiong, Z., Zhao, L., Wang, F., Zhu, J. et al., Synthesis of branched PEG brushes hybrid hydrophilic magnetic nanoparticles for the selective enrichment of N-linked glycopeptides. Chem. Commun. 2012, 48, 8138-8140.
48. Kuo, C. W., Wu, I. L., Hsiao, H. H., Khoo, K. H., Rapid glycopeptide enrichment and N-glycosylation site mapping strategies based on amine-functionalized magnetic nanoparticles. Anal. Bioanal. Chem. 2012, 402, 2765-2776.
49. Dam, T. K., Gerken, T. A., Brewer, C. F., Thermodynamics of multivalent carbohydrate-lectin cross-linking interactions: importance of entropy in the bind and jump mechanism. Biochemistry 2009, 48, 3822-3827.
50. Ueda, K., Takami, S., Saichi, N., Daigo, Y. et al., Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes. Mol. Cell. Proteomics 2010, 9, 1819-1828.
51. Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T. et al., Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21, 667-672.
52. Kaji, H., Shikanai, T., Sasaki-Sawa, A., Wen, H. et al., Large-scale identification of N-glycosylated proteins of mouse tissues and construction of a glycoprotein database, GlycoProtDB. J. Proteome Res. 2012, 11, 4553-4566.
53. Liu, T. W., Kaji, H., Togayachi, A., Ito, H. et al., A chemoenzymatic approach toward the identification of fucosylated glycoproteins and mapping of N-glycan sites. Glycobiology 2012, 22, 630-637.
54. Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H. et al., A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics. FEBS J. 2010, 277, 95-105.
55. Sugahara, D., Kaji, H., Sugihara, K., Asano, M. et al., Large-scale identification of target proteins of a glycosyltransferase isozyme by lectin-IGOT-LC/MS, an LC/MS-based glycoproteomic approach. Sci. Rep. 2012, 2, 680.
56. Han, H., Stapels, M., Ying, W., Yu, Y. et al., Comprehensive characterization of the N-glycosylation status of CD44s by use of multiple mass spectrometry-based techniques. Anal. Bioanal. Chem. 2012, 404, 373-388.
57. Zhang, S., Liu, X., Kang, X., Sun, C. et al., iTRAQ plus 18O: a new technique for target glycoprotein analysis. Talanta 2012, 91, 122-127.
58. Kubota, K., Sato, Y., Suzuki, Y., Goto-Inoue, N. et al., Analysis of glycopeptides using lectin affinity chromatography with MALDI-TOF mass spectrometry. Anal. Chem. 2008, 80, 3693-3698.
59. Snovida, S. I., Bodnar, E. D., Viner, R., Saba, J. et al., A simple cellulose column procedure for selective enrichment of glycopeptides and characterization by nano LC coupled with electron-transfer and high-energy collisional-dissociation tandem mass spectrometry. Carbohydr. Res. 2010, 345, 792-801.
60. Wada, Y., Tajiri, M., Yoshida, S., Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal. Chem. 2004, 76, 6560-6565.
61. Davies, M., Smith, K. D., Harbin, A. M., Hounsell, E. F., High-performance liquid chromatography of oligosaccharide alditols and glycopeptides on a graphitized carbon column. J. Chromatogr. 1992, 609, 125-131.
62. Davies, M. J., Smith, K. D., Carruthers, R. A., Chai, W. et al., Use of a porous graphitised carbon column for the high-performance liquid chromatography of oligosaccharides, alditols and glycopeptides with subsequent mass spectrometry analysis. J. Chromatogr. 1993, 646, 317-326.
63. Fan, J. Q., Kondo, A., Kato, I., Lee, Y. C., High-performance liquid chromatography of glycopeptides and oligosaccharides on graphitized carbon columns. Anal. Biochem. 1994, 219, 224-229.
64. Thaysen-Andersen, M., Mysling, S., Hojrup, P., Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. Anal. Chem. 2009, 81, 3933-3943.
65. Lam, M. P., Lau, E., Siu, S. O., Ng, D. C. et al., Online combination of reversed-phase/reversed-phase and porous graphitic carbon liquid chromatography for multicomponent separation of proteomics and glycoproteomics samples. Electrophoresis 2011, 32, 2930-2940.
66. Selman, M. H., McDonnell, L. A., Palmblad, M., Ruhaak, L. R. et al., Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 2010, 82, 1073-1081.
67. Zeng, Z., Hincapie, M., Pitteri, S. J., Hanash, S. et al., A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome. Anal. Chem. 2011, 83, 4845-4854.
68. Yang, Z., Hancock, W. S., Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr. A 2004, 1053, 79-88.
69. Yang, Z., Hancock, W. S., Monitoring glycosylation pattern changes of glycoproteins using multi-lectin affinity chromatography. J. Chromatogr. A 2005, 1070, 57-64.
70. Dayarathna, M. K., Hancock, W. S., Hincapie, M., A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: application to the analysis of obesity, diabetes, and hypertension diseases. J. Sep. Sci. 2008, 31, 1156-1166.
71. Kullolli, M., Hancock, W. S., Hincapie, M., Preparation of a high-performance multi-lectin affinity chromatography (HP-M-LAC) adsorbent for the analysis of human plasma glycoproteins. J. Sep. Sci. 2008, 31, 2733-2739.
72. Zheng, X., Wu, S. L., Hincapie, M., Hancock, W. S., Study of the human plasma proteome of rheumatoid arthritis. J. Chromatogr. A 2009, 1216, 3538-3545.
73. Qiu, R., Regnier, F. E., Use of multidimensional lectin affinity chromatography in differential glycoproteomics. Anal. Chem. 2005, 77, 2802-2809.
74. Hang, H. C., Yu, C., Kato, D. L., Bertozzi, C. R., A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc. Natl. Acad. Sci. USA 2003, 100, 14846-14851.
75. Laughlin, S. T., Bertozzi, C. R., Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation. Nat. Protoc. 2007, 2, 2930-2944.
76. Slade, P. G., Hajivandi, M., Bartel, C. M., Gorfien, S. F., Identifying the CHO secretome using mucin-type O-linked glycosylation and Click-chemistry. J. Proteome Res. 2012, 11, 6175-6186.
77. Dube, D. H., Prescher, J. A., Quang, C. N., Bertozzi, C. R., Probing mucin-type O-linked glycosylation in living animals. Proc. Natl. Acad. Sci. USA 2006, 103, 4819-4824.
78. Laughlin, S. T., Baskin, J. M., Amacher, S. L., Bertozzi, C. R., In vivo imaging of membrane-associated glycans in developing zebrafish. Science 2008, 320, 664-667.
79. Hart, C., Chase, L. G., Hajivandi, M., Agnew, B., Metabolic labeling and click chemistry detection of glycoprotein markers of mesenchymal stem cell differentiation. Methods Mol. Biol. 2011, 698, 459-484.
80. Foo, J. Y., Wan, Y., Kostner, K., Arivalagan, A. et al., NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS One 2012, 7, e48452.
81. Pfluger, M., Kapuscik, A., Lucas, R., Koppensteiner, A. et al., A combined impedance and AlphaLISA-based approach to identify anti-inflammatory and barrier-protective compounds in human endothelium. J. Biomol. Screen. 2012, 18, 67-74.
82. Peters, C. D., Jespersen, B., Norregaard, R., AlphaLISA versus ELISA-based detection of interleukin 18 in healthy subjects and patients with end-stage renal disease. Scand. J. Clin. Lab. Invest. 2012, 72, 583-592.
83. Cosentino, G., AlphaLISA assays to improve the vaccine development process. Dev. Biol. 2012, 134, 107-111.
84. Waller, H., Chatterji, U., Gallay, P., Parkinson, T. et al., The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A. J. Virol. Methods 2010, 165, 202-210.
85. Biancotto, A., Feng, X., Langweiler, M., Young, N. S. et al., Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. Cytokine 2012, 60, 438-446.
86. Kim, Y. W., Bae, S. M., Lim, H., Kim, Y. J. et al., Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers. PLoS One 2012, 7, e44960.
87. Rinewalt, D., Shersher, D. D., Daly, S., Fhied, C. et al., Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J. Thorac. Cardiovasc. Surg. 2012, 144, 1344-1351.
88. Tait, B. D., Hudson, F., Cantwell, L., Brewin, G. et al., Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology 2009, 14, 247-254.
89. Picascia, A., Infante, T., Napoli, C., Luminex and antibody detection in kidney transplantation. Clin. Exp. Nephrol. 2012, 16, 373-381.
90. Drouin, J., Izaguirre, C. A., Patenaude, P., Quantitation of cell membrane glycoproteins in pathological conditions using a lectin-bound enzyme-linked immunosorbent assay (ELISA). Application to human platelets in the Bernard-Soulier syndrome. J. Immunol. Methods 1988, 110, 217-223.
91. Tojo, M., Shibata, N., Osanai, T., Mikami, T. et al., Sandwich enzyme-linked immunosorbent assay of D-mannans of Candida albicans NIH A-207 and NIH B-792 strains using concanavalin A and polyclonal rabbit anti-C. albicans antisera. Carbohydr. Res. 1991, 213, 325-330.
92. Parker, N., Lectin/Antibody "sandwich" ELISA for quantification of circulating mucin as a diagnostic test for pancreatic cancer. Methods Mol. Med. 1998, 9, 249-253.
93. Parker, N., Makin, C. A., Ching, C. K., Eccleston, D. et al., A new enzyme-linked lectin/mucin antibody sandwich assay (CAM 17.1/WGA) assessed in combination with CA 19-9 and peanut lectin binding assay for the diagnosis of pancreatic cancer. Cancer 1992, 70, 1062-1068.
94. Yiannakou, J. Y., Newland, P., Calder, F., Kingsnorth, A. N. et al., Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer. Lancet 1997, 349, 389-392.
95. Takeda, Y., Shinzaki, S., Okudo, K., Moriwaki, K. et al., Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer 2012, 118, 3036-3043.
96. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T. et al., Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 2006, 118, 2803-2808.
97. Miyoshi, E., Shinzaki, S., Moriwaki, K., Matsumoto, H., Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test. Methods Enzymol. 2010, 478, 153-164.
98. Matsumoto, H., Shinzaki, S., Narisada, M., Kawamoto, S. et al., Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer. Clin. Chem. Lab. Med. 2010, 48, 505-512.
99. Toyama, A., Nakagawa, H., Matsuda, K., Sato, T. A. et al., Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring. Anal. Chem. 2012, 84, 9655-9662.
100. Medzihradszky, K. F., Characterization of site-specific N-glycosylation. Methods Mol. Biol. 2008, 446, 293-316.
101. Scott, N. E., Parker, B. L., Connolly, A. M., Paulech, J. et al., Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol. Cell. Proteomics 2011, 10, M000031-MCP000201.
102. Lemoine, J., Fortin, T., Salvador, A., Jaffuel, A. et al., The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation. Expert Rev. Mol. Diagn. 2012, 12, 333-342.
103. Kitteringham, N. R., Jenkins, R. E., Lane, C. S., Elliott, V. L. et al., Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B 2009, 877, 1229-1239.
104. Shi, T., Su, D., Liu, T., Tang, K. et al., Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 2012, 12, 1074-1092.